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1. Introduction
Gastric carcinoma is the second most common malignancy worldwide and surgical treatment
remains the only curative management option. Early gastric carcinoma (EGC) is defined as a
lesion of the stomach confined to the mucosa and/or submucosa, regardless of the lymph node
metastatic status. The incidence of EGC has gradually increased with advances in diagnostic
techniques and equipment [1-3]. In the West, EGC accounts for 4 - 16% of all gastric carcinoma
cases [4.5], whereas the proportion of EGC in Japan is approximately 30 - 50% [4-6].
The presence of a lymph node metastasis is one of the most important prognostic indicators for
EGC. Lymph node metastases occur during the early stage of gastric carcinoma, and regional
lymphadenectomy is the recommended surgical treatment of this disease. Excellent curative
outcomes for patients with EGC have been obtained with regional lymphadenectomy [4,7].
In this article, the basic concept of EGC is revisited and recent published articles on both
new diagnostic and treatment modalities are reviewed.
2. Classification of EGC
2.1. Macroscopic classification
The Japanese “gastric cancer” classification groups all gastric cancers into types 1 to 4 ac‐
cording to their morphological appearance [8]. EGC has been added as type 0, which is sub‐
divided according to the macroscopic appearance of the lesion: 0-I, protruded or polypoid;
0-II, superficial; 0-III, excavated lesion characterized by a deep ulcer-like excavation that can
resemble benign ulceration. Type 0-II lesions are most prevalent and are further subdivided
into IIa (elevated), IIb (superficial spread), and IIc (depressed).
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2.2. Microscopic classification
There has been considerable controversy between Japanese and Western pathologists re‐
garding the histological reporting of mucosal lesions. Some observers have suggested that
the reported incidence of EGC in Japan could be attributed to the over-diagnosis of dysplas‐
tic lesions as invasive cancer. Japanese pathologists often use the term, gastric cancer,
whereas western pathologists use the term, dysplasia. Western pathologists require evi‐
dence of cellular invasion into the lamina propria before they consider that the basement
membrane has been breached and can make a diagnosis of invasive cancer. Japanese pathol‐
ogists have traditionally relied on nuclear features such as enlargement, pleomorphism,
prominent nucleoli, and loss of polarity along with glandular architectural cancer diagnosis.
In 1965, Lauren described two histological subtypes of gastric cancer: intestinal and diffuse [9].
Since that time the Lauren classification scheme has been used worldwide. The intestinal-type
gastric cancer consists of a cohesive group of neoplastic cells that form distinct well-defined
tubular structures. In contrast, cell cohesion is lost in diffuse-type gastric cancer and individual
cells infiltrate the gastric wall without a glandular structure. This description closely resem‐
bles the Japanese classification of differentiated (papillary, well-differentiated adenocarcino‐
ma  or  moderately-differentiated  adenocarcinoma)  and  undifferentiated  types  (poorly-
differentiated adenocarcinoma, signet ring cell carcinoma, mucinous carcinoma).
3. Diagnostic challenges for early gastric cancer
Double contrast barium meal studies have been employed for more than 40 years in Japan,
but endoscopy shows higher sensitivity in EGC detection.
3.1. Indigo carmine chromoendoscopy
To achieve a successful outcome, it is very important to accurately determine the lateral ex‐
tent of a tumor. Traditionally, this has been done with conventional endoscopy and chro‐
moendoscopy using indigo carmine dye [3]. However, it is sometimes difficult to identify
the margins of the tumors, especially those of superficial or flat-type tumors. Chromoendo‐
scopy with indigo carmine dye added to acetic acid (AI chromoendoscopy) has been recent‐
ly reported to improve the diagnostic yield by aiding the recognition of the tumor borders in
patients with EGC [10].
Chromoendoscopy of a differentiated adenocarcinoma is shown in Fig. 1. A combined flat and
elevated lesion with an unclear border is located at the middle of the stomach (Fig. 1a). The bor‐
ders of the lesion becomes distinct with high image clarity in an endoscopic view after indigo
carmine was sprinkled onto the lesion (Fig. 1b). The lesion was resected by endoscopic submu‐
cosal dissection (ESD) and was shown to be a differentiated adenocarcinoma.
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Figure 1. Chromoendoscopic imaging. (a) A combined flat and elevated lesion with an unclear border at the middle
of the stomach is shown. (b) Endoscopic view of the lesion after indigo carmine was sprinkled onto it. The borders of
the lesion became distinct with high clarity images after chromoendoscopy with indigo carmine dye.
3.2. Magnifying narrow-band imaging endoscopy
The survival rate for patients who were treated for EGC is excellent, but the prognosis for
advanced gastric cancer is very poor. Therefore, an early diagnosis of gastric cancer is very
important but diagnosis is difficult because most patients with EGC do not have specific
symptoms and it is difficult to distinguish EGC from a benign peptic ulcer or gastritis. Tech‐
nological developments have enabled novel endoscopic imaging modalities such as magni‐
fying narrow-band imaging (NBI) endoscopy to be used recently for the diagnosis of early
gastric cancer [11,12].
Figure 2. Magnifying endoscopy with narrow-band imaging findings. (a) Conventional endoscopy with white light
imaging demonstrates that this lesion (arrow) should be classified as a pale lesion rather than a red-colored lesion. (b)
Magnifying endoscopy with narrow-band imaging findings (arrows) showed that this lesion should be diagnosed as
cancer by the presence of an irregular microvascular pattern plus an irregular microsurface pattern using the vessel
plus surface classification system.
A representative case of EGC is shown in Fig. 2. Conventional endoscopy with white light
imaging demonstrated that this lesion (arrow) should be classified as a pale lesion rather
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than a red-colored lesion (Fig. 2a). Magnifying endoscopy with narrow-band imaging was
used to diagnose the lesion as cancerous. The vessel plus surface classification system was
used to identify features including the presence of an irregular microvascular pattern to‐
gether with an irregular microsurface pattern (Fig. 2b). The histopathological diagnosis of
the resected specimen was EGC.
4. Management of early gastric cancer
4.1. Endoscopic mucosal resection (EMR)
EMR has been used as the standard treatment of EGR because there is no risk of lymph node
metastasis, and it is a minimally invasive, safe, convenient, and efficacious procedure. In or‐
der for EMR to be considered potentially curative, there are two important conditions that
should be met: complete en-bloc removal with a clear margin around the primary tumor,
and zero or extremely low possibility of lymph node metastasis. The Japanese Gastric Can‐
cer Association has proposed the following indications for curative EMR: (a) invasion is clin‐
ically confined to the mucosa, (b) tumor size of 2 cm or smaller, (c) histologically
differentiated type, (d) no ulcer or ulcer scar in the lesion [13]. A tumor that satisfies all of
these indications can be safely removed by EMR but if the tumor depth is histologically di‐
agnosed as mucosal, then lymph node metastasis should be absent.
Endoscopic submucosal dissection (ESD) is a newly developed technique in the field of en‐
doscopic treatments for EGC in Japan. This technique uses specialized devices, including an
insulation-tipped diathermy knife (IT knife), to dissect directly along the submucosal layer.
Although the drawbacks of ESD include its technical difficulty and a higher risk of proce‐
dure-related complications, it has replaced EMR in Japan, and it has been introduced in Ko‐
rea and Europe. Large numbers of ESD procedures are promising with high rates of both en-
bloc resection and curative resection. The risk factors associated with the resectability and
curability of ESD have been recently reported [14].
EGCs without any lymph node metastasis were treated with ESD using an IT knife (Fig. 3a).
Briefly, the markings along the presumed cutting line were first defined relative to the nor‐
mal mucosa that surrounded the lesion. This was performed with a standard needle knife at
least 5 mm away from the tumor (Fig. 3b). An epinephrine solution (0.025 mg/mL in saline
solution) was injected into the submucosa along the presumed cutting line and a standard
needle-knife was used to make a pre-cut outside the indicated area. The IT knife was insert‐
ed into the incision, and an electrosurgical current was applied by a standard electrosurgical
generator to complete the incision around the lesion (Fig. 3c). After the circumferential cut
was completed, a solution of epinephrine was injected into the submucosa below the lesion
when needed. The IT knife was then used to dissect the submucosa. If the tissue did not lift
during or after injection, the IT knife or the standard needle-knife was used to carefully dis‐
sect the tissue along the plane of the submucosa (Fig. 3d).
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Figure 3. ESD technique. (a) EGCs that were diagnosed with no lymph node metastasis were treated with ESD with an
IT knife. (b) Electrocautery marking surrounding the target lesion. (c) Submucosal injection of diluted epinephrine with
indigo carmine, and circumferential cutting around the lesion. (d) Completion of resection. ESD was performed by an
experienced gastrointestinal endoscopist (Dr. Hajime Yamaoka at Kochi Medical School, JAPAN).
4.2. Gastric surgery
Subtotal or total gastrectomy with regional lymphadenectomy is the standard treatment for
resectable gastric cancer in Japan and Korea as well as high-volume centers in other coun‐
tries. Less invasive gastrectomy with limited lymphadenectomy, such as pylorus-preserving
gastrectomy and proximal gastrectomy, has been proposed for EGC that has a low possibili‐
ty of nodal metastasis and a high probability of cure [15].
A typical gastrectomy with regional lymphadenectomy is shown in Fig. 4. After division of
the left gastric artery, the lymphatic and connective tissue was removed from the surface of
diaphragmatic crus that covers the aorta and the posterior aspect of the esophageal hiatus
was exposed (Fig. 4a). Immediate inspection of the resected stomach revealed a tumor of the
distal stomach, and the lymphadenectomy of supramesentric vein was performed (Fig. 4b).
Laparoscopic-assisted gastrectomy (LAG) has been used to treat EGC, which requires less ex‐
tensive lymph node dissection. The use of LAG for EGC was first reported in 1994 [16] and
many studies have since reported on the benefits of the technique, which include reduced
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blood loss, decreased pain, early recovery of bowel movements, and a short hospital stay [17].
Other studies have focused on its oncologic equivalency to open gastrectomy but the techni‐
que does involve a steep surgical learning curve [18]. Recently, the indication for LAG in some
high-volume centers has been extended to include advanced gastric cancer [19].
Figure 4. Standard gastrectomy. (a) The lymphatic and connective tissue was removed from the surface of diaphrag‐
matic crus that covers the aorta after division of the left gastric artery. The posterior aspect of the esophageal hiatus
was exposed. (b) Immediate inspection of the resected stomach revealed a tumor of the distal stomach, and the lym‐
phadenectomy of supramesentric vein was added. Total gastrectomy was performed by Dr. Takeshi Sano (Cancer Insti‐
tute Hospital, JAPAN).
4.3. Reconstruction after gastric resection
Various reconstructive procedures have been proposed for patients undergoing distal gas‐
trectomy for gastric cancer. In general, Billroth I (BI) reconstruction is the most common
technique used clinically because it involves relatively simple reconstruction. However, bile
reflux resulting in remnant gastritis and gastroesophageal reflux disease (GERD) has been
noted as a problem associated with BI reconstruction after distal gastrectomy. Some studies
have indicated that Roux-en-Y (RY) reconstruction following distal gastrectomy is superior
to BI reconstruction in preventing remnant gastritis and reflux esophagitis because it re‐
duces duodenogastric and gastroesophageal reflux [20]. The disadvantages of RY recon‐
struction include the possible development of stomal ulcers, increased probability of
cholelithiasis, increased difficulty with an endoscopic approach to the papilla of Vater, and
the possibility of Roux stasis syndrome. Furthermore, the RY reconstruction technique has a
different route of reconstruction whereby all food passes through the jejunum and bypasses
the duodenum, which causes one of the disadvantages of this procedure. An additional
problem caused by RY reconstruction is the considerable difficulty with endoscopic access
to the papilla of Vater for the diagnosis or treatment of pancreatobiliary disorders that may
develop after the distal gastrectomy. Recently, double tract reconstruction (DT) after either
total or subtotal gastrectomy have been introduced to remove the disadvantage of RY recon‐
struction [21]. DT reconstruction is as simple as RY reconstruction and can be performed
safely after distal gastrectomy with regional lymphadenectomy. The advantages of DT re‐
construction following both total and distal gastrectomy include maintaining the physiologi‐
cal passage of food and allowing future diagnostic and therapeutic endoscopic interventions
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to be safely performed. The technique chosen for surgical reconstruction of the gastrointesti‐
nal tract to perform gastrojejunostomy should take potential future endoscopic require‐
ments into account (Fig. 5).
Figure 5. Double tract reconstruction after gastrectomy. (a) Double tract reconstruction (DT) after subtotal gastrecto‐
my. (b) DT after total gastrectomy. Gastrectomy was performed by Dr. Tsutomu Namikawa and Dr. Michiya Kobayashi
(Kochi Medical School, JAPAN).
5. Prognosis of EGC
The incidence of lymph node metastasis has been reported to be 5.7 - 20% and it is one of the
most important factors in determining the prognosis of patients with EGC [22-24]. Excellent
curative treatment for patients with EGC has been obtained with regional lymphadenectomy
[25]. Less invasive treatments, including EMR and ESD, have been performed recently for EGC
and these options should be considered when deciding on a treatment method [26-29].
Experienced endoscopists are able to accurately evaluate the extent of lesions in gastric car‐
cinoma and therefore, less invasive treatments such as EMR or ESD, may become possible
for EGC with tumors less than 2 cm in diameter [30]. Use of the endoscopic scale for measur‐
ing the size of the EGC and endoscopic ultrasonography can be effective because the exact
tumor diameter is not always easy to determine endoscopically. The use of EMR and/or ESD
has become a reasonable and convenient diagnostic and treatment modality, because histo‐
logical information about the whole tumor can be obtained. Furthermore, a curative treat‐
ment is achieved in the case of localized tumors without lymph node metastasis, which
preserves the whole stomach. In recent years, the use of EMR and/or ESD has become safe
and effective curative treatment option with feasible clinical outcomes in patients with EGC.
As a result, the use of EMR and/or ESD has ensured an excellent prognosis, and should be
the first choice of treatment in patients with EGC, although careful histological examination
and long-term endoscopic surveillance remain important. When lymphatic permeation or
vascular invasion is recognized in post-resection specimens, additional surgical resection of
the stomach with lymphadenectomy is recommended [31,32]. Further prospective studies
are warranted to evaluate the efficacy of this therapeutic strategy.




EGC is a curable disease in many cases, and a variety of less invasive, function-preserving
treatments have been proposed. The use of EMR and/or ESD has ensured an excellent prog‐
nosis for patients who were suffering from EGC with no lymph node metastasis. Lymph
node metastasis was one of the most important factors in determining the prognosis of pa‐
tients with EGC. Therefore, when lymphatic permeation or vascular invasion is recognized
in post-resection specimens of either EMR or ESD, additional surgical resection of the stom‐
ach with lymphadenectomy is recommended.
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